Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US Approvals Analysis: Molecular Dx Innovations Make Waves In November

Dec 13 2017

• By David Filmore

FDA approved background, 3D rendering, blue street sign

Related Content

Neurostimulator Is First Device Marketed To Reduce Opioid Withdrawal Symptoms

Nov 15 2017

A New York Minute: US FDA Leverages State's Health Department To Expedite NGS Reviews

Nov 15 2017

First Expedited NGS Test Breaks Through FDA Review

Dec 01 2017

Related Companies

Foundation Medicine, Inc.

DxNA LLC

bioMerieux SA

Additional Topics

United States Approvals FDA In Vitro Diagnostics Medical Device

More from Approvals

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window